Specialty Drug Utilization Grows
The Navitus 2024 Drug Trend Report found that specialty medications accounted for less than 2% of utilization but drove 52% of net drug spending in 2024. The report highlights how increased use of drugs like Dupixent, oncology therapies and GLP-1 therapies increased overall prescription drug costs.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
CLARITY FOR ACTION
Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download
Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.
Related blogs
Navigating Healthcare and Improving Outcomes
Don’t Sign Here – The 7 Red Flags of PBM Contracts
Signing with a new pharmacy benefit manager (PBM) can be a daunting experience, with hundreds or thousands of plan members depending on that choice. And in this opaque industry, it is important to look beyond the initial conversations with a PBM when…
